Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG35487

ITGB3 Knockout CaSki Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Uterus (cervix)

  • Disease:

    Squamous cell carcinoma

CRISPR/Cas9-edited polyclonal ITGB3 knockout pool of Ca Ski cells. Loss of integrin ??3 disrupts ??V??3/??IIb??3 heterodimer formation, impairing adhesion to vitronectin and fibronectin and attenuating FAK/Src, PI3K/Akt, and ERK signaling. The HPV-16 E6/E7-positive cervical carcinoma background provides a relevant context for dissecting ??3 integrin roles in HPV-driven oncogenesis. This model supports functional studies of cervical cancer adhesion, migration, invasion, and drug resistance. Typical applications include cell adhesion, Boyden chamber, and Matrigel invasion assays; phospho-FAK and phospho-Akt Western blotting; immunofluorescence; flow cytometry; and xenograft experiments, facilitating research on metastasis and angiogenesis.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    CaSki

    Sex of Donor

    Female

    Age

    40 years

    Derived From Site

    Metastatic; Small intestine

    Gene Name

    Itgb3

    Gene Identifier

    NCBI Gene ID 3690

    Morphology

    Epithelial-like

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    RPMI 1640

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The ITGB3 Knockout Ca Ski Polyclonal Cells comprise a CRISPR/Cas9-mediated gene-disrupted polyclonal population of Ca Ski cells, targeting the ITGB3 locus that encodes the ??3 integrin subunit. This heterogeneous knockout pool abrogates functional ??3 integrin expression, preventing formation of ??V??3 and ??IIb??3 heterodimers. The product serves as a loss?of?function tool for interrogating integrin?dependent adhesion, migration, and signal transduction in a defined cervical carcinoma background.

The parental Ca Ski line is an adherent epithelial cell model derived from a human cervical epidermoid carcinoma. It maintains multiple integrated copies (60?C600) of the high?risk human papillomavirus type 16 (HPV?16) genome and stably expresses the viral E6 and E7 oncoproteins, which inactivate tumor suppressors p53 and Rb. This genotype drives sustained proliferation and genomic instability, rendering Ca Ski cells a widely employed platform for studying HPV?mediated carcinogenesis, host?virus interactions, and therapeutic responses in cervical cancer.

ITGB3 encodes integrin ??3, which heterodimerizes with ??V or ??IIb to form receptors for vitronectin, fibronectin, fibrinogen, and other RGD ligands. Ligand binding induces talin- and kindlin-dependent activation, triggering the FAK?Src complex to propagate downstream signals. This cascade bifurcates into the PI3K?AKT?mTOR survival pathway and the Ras?Raf?MEK?ERK proliferative axis, while also controlling Rho GTPases (Rac1, CDC42, RhoA) that regulate cytoskeletal dynamics and focal adhesion turnover. Upstream modulators include VEGF, TGF???, PDGF, FGF, ECM stiffness, osteopontin, and IL?1??; the integrin also associates laterally with VEGFR2, PDGFR, and MMP2 to coordinate adhesion with growth factor and proteolytic signaling.

In the Ca Ski context, knockout of ITGB3 abolishes ??3?containing integrin heterodimers, thereby eliminating adhesion to vitronectin and fibronectin and attenuating outside?in signaling. This manifests as reduced phosphorylation of FAK Tyr397, Src Tyr416, Akt Ser473, and ERK1/2, along with impaired cytoskeletal reorganization and Rho GTPase activity. The cells consequently show decreased migration and invasion, and heightened sensitivity to anoikis. Because Ca Ski cells express HPV?16 E6/E7, the knockout also provides a unique platform to examine whether ??3 integrins synergize with viral oncoproteins to sustain anchorage?independent growth and metastatic dissemination.

Researchers can employ these polyclonal knockout cells in a range of functional assays, including adhesion assays on vitronectin or fibronectin substrates, Boyden chamber migration and Matrigel invasion assays, phospho?specific Western blotting for FAK, Akt, and ERK, immunofluorescence visualization of focal adhesions and actin stress fibers, flow cytometric apoptosis quantification, Rho GTPase activation measurements, and xenograft tumorigenicity studies. These applications are particularly suited to investigations of cervical cancer metastasis, integrin?mediated drug resistance, angiogenesis, and HPV?host interactions. For additional product details, pricing, or a quotation, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)